As we've seen, the testing data for AS is off the charts. But years of going through the regulatory process, especially under the past Administration has been lined with red tape... I think it's an argument some members of Congress would at least look into. If not for the potential of saving lives, perhaps in fairness then...
Management issues aside, AS is a poster child for what happens when innovation is confronted by monolithic gov't regs and agencies.
News 
Market Data 
Discover 
AI
